Document is current
Any future updates will be listed below
-
Authors
Trahtemberg, Uriel
Fritzler, Marvin J. http://orcid.org/0000-0003-1652-6608
,
Rottapel, Robert
dos Santos, Claudia C.
Di Battista, Alex P.
Slutsky, Arthur S.
Baker, Andrew J.
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04747782 at ClinicalTrials.govDocuments that mention this clinical trial
COVID-19-associated autoimmunity as a feature of acute respiratory failure
https://doi.org/10.1007/s00134-021-06408-z
Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients (Results)
https://doi.org/10.1136/annrheumdis-2021-220206
-
Funding
Funding for this research was provided by:
St. Michael's Hospital Foundation
MitogenDx
- License Information
-
More Information
Article History
Received: 5 April 2021
Accepted: 8 April 2021
First Online: 30 April 2021
Declarations
:
: MJF is the Director of MitogenDx. MJF is a consultant for and received speaking honoraria from Inova Diagnostics Inc (San Diego, CA) and Werfen International (Barcelona, Spain). All the other authors have no disclosures to declare.
: This research was approved by the Research Ethics Boards of St Michael’s Hospital and performed in accordance with the Helsinki Declaration of 1975 as revised in 2013.
: Informed consent was obtained from all patients or surrogate decision makers when available. Otherwise, as per the study’s protocol and as approved by the REB, given the minimal-risk nature of the study, a deferred consent model was invoked while continuing to pursue direct consent throughout the study period.
: NCT04747782—clinicaltrials.gov.
